Journal profile · Integrative & Complementary Medicine

Journal of Ethnopharmacology

ISSN 0378-8741 · eISSN 1872-7573 · Elsevier Ireland Ltd · IRELAND · Semimonthly · Founded 1979

Journal of Ethnopharmacology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.72; hybrid open access; APC about USD 3,740; median 81 days to acceptance (91 articles, last 24 months); community-reported acceptance: about 55.45%; 1,637 articles in 2025; indexed in SCIE and Scopus.

Impact factor6.72Latest value listed by LetPub

CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine

Review time81 daysMedian, submission to acceptance · 91 articles, last 24 months · PubMed

APCUSD 3,740Hybrid journal: charged only for open-access articles

Acceptanceabout 55.45%Community average

Articles per year1,6372025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Ethnopharmacology is published by Elsevier Ireland Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ethnobotanical and Medicinal Plants Studies, Traditional Chinese Medicine Analysis and Phytochemistry and Biological Activities, together about 27.8% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)

Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.

From the journal's Aims & Scope

Research area (LetPub): Integrative & Complementary Medicine

Main research topics OpenAlex counts of recent articles; shares are approximate

Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences11.7%
Traditional Chinese Medicine AnalysisMedicine9.5%
Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences6.6%
Natural Antidiabetic Agents StudiesMedicine5.5%
Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences5.3%
Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology5%
Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics4.3%
Berberine and alkaloids researchMedicine3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Integrative & Complementary Medicine	Zone 1
Minor	Pharmacology & Pharmacy	Zone 1
Minor	Chemistry, Medicinal	Zone 2
Minor	Plant Sciences	Zone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Plant Sciences	Zone 1
Minor	Chemistry, Medicinal	Zone 1
Minor	Integrative & Complementary Medicine	Zone 1
Minor	Pharmacology & Pharmacy	Zone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2

Level	Category	Zone
Major	Medicine	Zone 2
Minor	Chemistry, Medicinal	Zone 1
Minor	Integrative & Complementary Medicine	Zone 1
Minor	Pharmacology & Pharmacy	Zone 1
Minor	Plant Sciences	Zone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor: 6.72LetPub · 2026-09-13
CiteScore 2026-06: 11.2LetPub · 2026-09-13
SJR 2026-06: 1.28LetPub · 2026-09-13
SNIP 2026-06: 1.55LetPub · 2026-09-13
h-index: 170LetPub · 2026-09-13
h-index: 307OpenAlex · 2026-10-01
i10-index: 15,926OpenAlex · 2026-10-01
2-year mean citedness: 5.64OpenAlex · 2026-10-01
Self-citation rate: 10.3%LetPub · 2026-09-13
Share of gold OA articles: 12.52%LetPub · 2026-09-13

Volume

Articles per year: 1,448LetPub · 2026-09-13

Articles by year OpenAlex count · 22,324 in total · the current year is incomplete

Year	Articles	Open access	Citations
2026	1,182	207	603
2025	1,637	283	6,217
2024	1,434	311	17,148
2023	1,408	283	26,287
2022	1,007	166	23,567
2021	1,064	168	31,434

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · 2024-10-05 to 2026-10-05

81 daysMedian, submission to acceptance · P25–P75 63 days – 107 days

Acceptance to online: median 1 days (91 articles)
Submission to online: median 83 days
Sample: 91 articles with submission and acceptance dates (3,650 in the window); the latest was accepted on 2026-07-29

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports): about 3 monthsLetPub · 2026-09-13
Average acceptance (community reports): 55.45%LetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

Source	APC	Fee waiver	License	Observed
OpenAlex	USD 3,740 / EUR 3,500 / GBP 2,990 / JPY 463,870	—	—	2026-10-01

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher: Elsevier Ireland Ltd
Country or region: IRELAND
Language: English
Frequency: Semimonthly
Founded: 1979
ISSN: 0378-8741
Electronic ISSN: 1872-7573
Official links: Journal homepage ↗OpenAlex
Submission system ↗LetPub

FAQ

Frequently asked questions about Journal of Ethnopharmacology

What CAS zone is Journal of Ethnopharmacology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Ethnopharmacology is in Zone 2 of Medicine, and in Zone 1 of the minor category Integrative & Complementary Medicine / Pharmacology & Pharmacy / Chemistry, Medicinal / Plant Sciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Journal of Ethnopharmacology?

The latest impact factor listed by LetPub is 6.72; CiteScore 11.2, h-index 307.

How long does peer review take at Journal of Ethnopharmacology?

Based on the dates recorded on 91 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 63–107 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 55.45%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Journal of Ethnopharmacology?

According to LetPub and DOAJ records, Journal of Ethnopharmacology is indexed in SCIE and Scopus.

Is Journal of Ethnopharmacology open access, and what is the APC?

Journal of Ethnopharmacology is a hybrid journal. For open-access publication: APC about USD 3,740.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: 2026-10-01.